Duvic M. Optimizing bexarotene therapy for cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 10 [cited 2024 Aug. 25];2(13). Available from: https://www.pagepress.org/journals/hmr/article/view/495